Special Issues

Special Issue Title: Recent Advances in Percutaneous Coronary Intervention

· Print Special Issue Flyer

· Deadline for manuscript submissions: 30 March 2022

Special Issue Editor

Guest Editor


  Prof. George Dangas, MD, PhD 

  Mount Sinai Hospital, NY, USA

Website | E-Mail

Prof. Christian Hengstenberg, MD, PhD 

Medical University of Vienna, Austria

Website | E-Mail

Special Issue Information

Dear Colleagues,

Management of coronary artery disease has substantially improved since the introduction of percutaneous transluminal coronary angioplasty by Doctor Andreas Grüntzig in 1977. Cardiac surgery was the prevailing revascularization strategy at that time, with percutaneous coronary intervention (PCI) reserved to patients with favorable coronary anatomy. Revolutionary changes in technologies have reverted the status quo such that most revascularization procedures are currently performed percutaneously. Introduction of new-generation drug-eluting stents with a superior design to bare-metal stents decreased the rates of complications and recurrent ischemic events on the short- and long-term follow-up. In particular, the incidence of stent thrombosis after PCI has significantly declined over the past years raising questions about the need for prolonged antiplatelet therapy duration. Furthermore, as newer and more potent antithrombotic agents are currently available, the main challenge remains to balance the bleeding and ischemic risks, especially in those that carry high bleeding risk characteristics. Advancements in intracoronary imaging technologies have allowed a more optimal stent deployment and implantation, mitigating the risk of early and late stent failure due to stent fracture and neoatherosclerosis formation. In addition, adoption of state-of-the-art devices, guidewires, and techniques has facilitated the treatment of complex coronary lesions. With a growing population of complex and high-risk patients, new-generation mechanical circulatory support devices have extended PCI indications to patients deemed ineligible for surgical revascularization. In this review series, we provide an overview on the recent advances in PCI, ranging from antithrombotic therapy, intracoronary imaging, treatment of complex lesions, and use mechanical circulatory support devices.     

Prof. George Dangas and Prof. Christian Hengstenberg

Guest Editors


Manuscript Submission Information

Manuscripts should be submitted online at https://rcm.imrpress.org by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Reviews in Cardiovascular Medicine is an international peer-reviewed open access quarterly journal published by IMR Press.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $1950. Submitted papers should be well formatted and use good English.


Percutaneous coronary intervention; Revascularization; Coronary artery disease; Ischemic heart disease; Antiplatelet therapy; Antithrombotic therapy; Coronary atherectomy; Angioplasty; Coronary stent

Share This Special Issue


Planned Paper

Title: Pharmacogenomics and Medical Management in Interventional Pharmacology: Present Status and Future Directions

Author(s): Christian Hengstenberg

Title: High risk PCI in the modern era

Author(s): Christian Hengstenberg

Title: Management of High-Bleeding Risk Patients Undergoing PCI: Devices & Pharmacotherapy

Author(s): Roxana Mehran

Title: Intracoronary Imaging in PCI

Author(s): George Dangas

Title: Treatment of complex coronary lesions

Author(s): George Dangas

Title:  Identification and preventative treatment of vulnerable plaques

Author(s): Bimmer Claessen

Title: Periprocedural myocardial infarction

Author(s): Jean-Philippe Collet

Please wait a minute...
For Selected: Toggle Thumbnails

Current Issue

  • Volume 22, Issue 3